$2.5T
Total marketcap
$201.89B
Total volume
BTC 50.11%     ETH 15.71%
Dominance

Royalty Pharma RPRX Stock

30.05 USD {{ price }} -0.132938% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
17.95B USD
LOW - HIGH [24H]
29.86 - 30.2 USD
VOLUME [24H]
1.71M USD
{{ volume }}
P/E Ratio
11.87
Earnings per share
2.53 USD

Royalty Pharma Price Chart

Royalty Pharma RPRX Financial and Trading Overview

Royalty Pharma stock price 30.05 USD
Previous Close 32.15 USD
Open 32.2 USD
Bid 0 USD x 1300
Ask 0 USD x 1200
Day's Range 31.96 - 32.36 USD
52 Week Range 31.96 - 44.66 USD
Volume 4.26M USD
Avg. Volume 2.12M USD
Market Cap 14.43B USD
Beta (5Y Monthly) 0.424231
PE Ratio (TTM) 44.10959
EPS (TTM) 2.53 USD
Forward Dividend & Yield 0.8 (2.46%)
Ex-Dividend Date May 18, 2023
1y Target Est 51.53 USD

RPRX Valuation Measures

Enterprise Value 23.53B USD
Trailing P/E 44.10959
Forward P/E 8.172589
PEG Ratio (5 yr expected) 1.27
Price/Sales (ttm) 6.1174946
Price/Book (mrq) 2.4245162
Enterprise Value/Revenue 9.973
Enterprise Value/EBITDA 19.879

Trading Information

Royalty Pharma Stock Price History

Beta (5Y Monthly) 0.424231
52-Week Change -18.17%
S&P500 52-Week Change 20.43%
52 Week High 44.66 USD
52 Week Low 31.96 USD
50-Day Moving Average 34.43 USD
200-Day Moving Average 38.4 USD

RPRX Share Statistics

Avg. Volume (3 month) 2.12M USD
Avg. Daily Volume (10-Days) 2.87M USD
Shares Outstanding 448.2M
Float 384.64M
Short Ratio 3.26
% Held by Insiders 24.84%
% Held by Institutions 68.54%
Shares Short 7.58M
Short % of Float 1.77%
Short % of Shares Outstanding 1.69%

Dividends & Splits

Trailing Annual Dividend Rate 0.77
Trailing Annual Dividend Yield 2.39%
5 Year Average Dividend Yield N/A
Payout Ratio 1.0405
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 14.06%
Operating Margin (ttm) 50.10%
Gross Margin 64.45%
EBITDA Margin 50.16%

Management Effectiveness

Return on Assets (ttm) 4.28%
Return on Equity (ttm) 6.12%

Income Statement

Revenue (ttm) 2.36B USD
Revenue Per Share (ttm) 5.35 USD
Quarterly Revenue Growth (yoy) 21.69%
Gross Profit (ttm) 1.33B USD
EBITDA 1.18B USD
Net Income Avi to Common (ttm) 331.83M USD
Diluted EPS (ttm) 0.73
Quarterly Earnings Growth (yoy) 558.30%

Balance Sheet

Total Cash (mrq) 1.98B USD
Total Cash Per Share (mrq) 4.41 USD
Total Debt (mrq) 7.12B USD
Total Debt/Equity (mrq) 72.5 USD
Current Ratio (mrq) 2.356
Book Value Per Share (mrq) 13.281

Cash Flow Statement

Operating Cash Flow (ttm) 2.72B USD
Levered Free Cash Flow (ttm) -1726824704 USD

Profile of Royalty Pharma

Country United States
State NY
City New York
Address 110 East 59th Street
ZIP 10022
Phone 212 883 0200
Website https://www.royaltypharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Q&A For Royalty Pharma Stock

What is a current RPRX stock price?

Royalty Pharma RPRX stock price today per share is 30.05 USD.

How to purchase Royalty Pharma stock?

You can buy RPRX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Royalty Pharma?

The stock symbol or ticker of Royalty Pharma is RPRX.

Which industry does the Royalty Pharma company belong to?

The Royalty Pharma industry is Biotechnology.

How many shares does Royalty Pharma have in circulation?

The max supply of Royalty Pharma shares is 597.43M.

What is Royalty Pharma Price to Earnings Ratio (PE Ratio)?

Royalty Pharma PE Ratio is 11.87747000 now.

What was Royalty Pharma earnings per share over the trailing 12 months (TTM)?

Royalty Pharma EPS is 2.53 USD over the trailing 12 months.

Which sector does the Royalty Pharma company belong to?

The Royalty Pharma sector is Healthcare.

Royalty Pharma RPRX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Composite Total Return I XCMP 19565.06 USD
+0.82
19553.78 USD 19740.18 USD
NASDAQ Q 50 NXTQ 737.55 USD
-0.27
737.3 USD 745.3 USD
Nasdaq Next Generation 100 Inde NGX 1138.09 USD
-0.13
1137.73 USD 1146.36 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Horizon Kinetics ISE Wealth Ind RCH 3192.05 USD
-0.39
3191.48 USD 3212.7 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD